Anavex Life Sciences (AVXL) Assets (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.10% |
| Sep 30, 2025 | 1.35% |
| Jun 30, 2025 | -12.56% |
| Mar 31, 2025 | -5.57% |
| Dec 31, 2024 | -8.50% |
| Sep 30, 2024 | -4.22% |
| Jun 30, 2024 | -2.06% |
| Mar 31, 2024 | -2.40% |
| Dec 31, 2023 | -4.09% |
| Sep 30, 2023 | -2.17% |
| Jun 30, 2023 | -0.86% |
| Mar 31, 2023 | 7.29% |
| Dec 31, 2022 | -2.84% |
| Sep 30, 2022 | -4.69% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | 2.15% |
| Dec 31, 2021 | -2.92% |
| Sep 30, 2021 | -2.89% |
| Jun 30, 2021 | 99.13% |
| Mar 31, 2021 | 53.82% |
| Dec 31, 2020 | 57.30% |
| Sep 30, 2020 | 9.21% |
| Jun 30, 2020 | 1.97% |
| Mar 31, 2020 | -1.28% |
| Dec 31, 2019 | 24.06% |
| Sep 30, 2019 | 15.30% |
| Jun 30, 2019 | 6.90% |
| Mar 31, 2019 | -7.00% |
| Dec 31, 2018 | -15.69% |
| Sep 30, 2018 | -2.20% |
| Jun 30, 2018 | 3.47% |
| Mar 31, 2018 | -8.64% |
| Dec 31, 2017 | 1.82% |
| Sep 30, 2017 | 11.77% |
| Jun 30, 2015 | 25.37% |
| Mar 31, 2015 | -9.73% |
| Dec 31, 2014 | -4.12% |
| Sep 30, 2014 | -21.05% |
| Jun 30, 2014 | -9.51% |
| Mar 31, 2014 | 6,721.34% |
| Dec 31, 2013 | -61.65% |
| Sep 30, 2013 | 11,206.01% |
| Jun 30, 2013 | 614.58% |
| Mar 31, 2013 | -99.39% |
| Dec 31, 2012 | 507.47% |
| Sep 30, 2012 | -40.58% |
| Jun 30, 2012 | -88.42% |